Zobrazeno 1 - 10 of 49 pro vyhledávání: '"V Shreenivas"'
2
Akademický článek
Application of thermoelectric cooling module for sampling of tritium in air
Autor: Lokesh Kumar, V Shreenivas, Saurav Sood, P Ashokkumar, Ranjit Sharma, M S Kulkarni
Publikováno v: Radiation Protection and Environment, Vol 45, Iss 1, Pp 16-21 (2022)
The sampling and measurement of airborne tritium is an essential component of workplace monitoring at heavy water handling facilities and nuclear reactors using heavy water as coolant and moderator. Tritium being an internal hazard, its workplace mon
Externí odkaz: https://doaj.org/article/8eca86a6b45540648e5bbef3ca307111
Zobrazit plný text záznamu
4
Akademický článek
Bone health in patients with Cushing's syndrome
Autor: Sk Hammadur Rahaman, Viveka P Jyotsna, Devasenathipathy Kandasamy, V Shreenivas, Nandita Gupta, Nikhil Tandon
Publikováno v: Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 6, Pp 766-769 (2018)
Introduction: Osteoporosis is a well-recognized complication of Cushing's syndrome (CS). Data on bone health in patients with CS from south Asian countries, which are vitamin D deficient, are scarce. Aims: We assessed bone mineral density (BMD) in pa
Externí odkaz: https://doaj.org/article/b680b2ed39174a009bcd7f333a346d78
Zobrazit plný text záznamu
7
Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis
Autor: Marie Parish, Ronald Cox, Aditya V. Shreenivas, Amit Mahipal, Sakti Chakrabarti
Publikováno v: Journal of Clinical Oncology. 41:89-89
89 Background: Enterocolitis is a potentially fatal toxicity of CAPE. The safety of infusional 5-FU-based regimens in patients developing severe enterocolitis with CAPE is not well established in the literature. Methods: After institutional review bo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a22106b630c4b8670ceb78aaa38b489
https://doi.org/10.1200/jco.2023.41.4_suppl.89
Zobrazit plný text záznamu
8
ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma
Autor: Maahum Mehdi, Bicky Thapa, Aniko Szabo, Gulrayz Ahmed, Aditya V. Shreenivas, James P. Thomas, Deepika Sriram, Douglas B. Evans, Susan Tsai, Kathleen K. Christians, Beth Erickson, William A. Hall, Thomas McFall, Steve Patrick, Ben George, Razelle Kurzrock, Mandana Kamgar
Publikováno v: Journal of Clinical Oncology. 41:754-754
754 Background: ATM and CHEK2 mutations are linked to homologous recombination DNA repair deficiency, with the potential for improved therapeutic response to DNA damaging agents. To investigate our clinical observation of improved outcomes with irino
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96217099535bae23a3e44a0266e92b05
https://doi.org/10.1200/jco.2023.41.4_suppl.754
Zobrazit plný text záznamu
9
The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world
Autor: Sakti Chakrabarti, Marie Parish, Carrie Peterson, Kirk A. Ludwig, Deepika Sriram, Antony Ruggeri, Sameer Tolay, Jennifer Eva Selfridge, David L Bajor, Amr Mohamed, Amit Mahipal, Aditya V. Shreenivas
Publikováno v: Journal of Clinical Oncology. 41:105-105
105 Background: Patients with potentially resectable dMMR/MSI-H colon cancer (CC) often receive neoadjuvant immunotherapy (IO) if co-morbid conditions or the extent of disease preclude upfront surgery. We investigated the outcome of such patients tre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9477b1b98e3882bcd5f08aa83f6205d
https://doi.org/10.1200/jco.2023.41.4_suppl.105
Zobrazit plný text záznamu
10
Impact of statin type and intensity on cisplatin-related hearing loss
Autor: Emilee McCullough, Aditya V. Shreenivas, Stephanie Spitzer, Michelle Schroeder, Aniko Szabo, David Friedland, Stuart J. Wong
Publikováno v: Journal of Clinical Oncology. 40:192-192
192 Background: Ototoxicity is a common and treatment-limiting side effect of cisplatin. Rates of permanent hearing loss due to cisplatin treatment range from 40 to 80% and are associated with considerable morbidity and negative impact on quality of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::900341fc07ce1edf5bdb3877469ff6c1
https://doi.org/10.1200/jco.2022.40.28_suppl.192
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje